End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
05-27 | Claranova: repayment of Euro PP bond | CF |
05-21 | Claranova: end of dispute with Canadian shareholders | CF |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company shows low valuation levels, with an enterprise value at 0.45 times its sales.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 134M | - | ||
+8.91% | 85.92B | B | ||
+5.14% | 77.93B | B+ | ||
-16.20% | 52.89B | B+ | ||
+26.18% | 48.28B | D+ | ||
+28.93% | 45.38B | D+ | ||
-34.05% | 40.83B | B- | ||
+66.72% | 38.78B | D+ | ||
-0.36% | 27.48B | C+ | ||
-26.47% | 21.52B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CLA Stock
- OXAVQ Stock
- Ratings Claranova